Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia

Title
Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA RESEARCH
Volume 34, Issue 2, Pages 129-134
Publisher
Elsevier BV
Online
2009-09-24
DOI
10.1016/j.leukres.2009.08.031

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started